Loading
The public content is loading. You can keep this page open while the route becomes available.
Understand the workflow, review model, governance evidence, and implementation questions to assess before adopting an AI medical scribe in a UK clinical setting.
In plain language
An AI medical scribe typically captures or accepts encounter audio, produces a transcript or structured draft, and gives a clinician a route to edit and approve the result. The useful question is not whether it uses AI; it is whether the complete workflow produces a safe, usable record with acceptable effort and governance.
What matters
Follow audio, transcript, draft, approved note, logs, backups, exports, and support access across every supplier and processing location.
Check whether clinically material facts remain traceable to the encounter and whether unsupported additions are easy to identify.
Define consent or transparency, devices, templates, record transfer, downtime, support, monitoring, and accountable owners.
Pilot method
Define the expected answer or evidence before the demonstration so the result can be assessed consistently.
Use representative examples, record what happens, and measure the work required to reach an acceptable final state.
Assign an owner to verify the current evidence, resolve gaps, and record any conditions before adoption.
Topic-specific review
These checks are specific to this decision and should be evidenced separately from the generic product demonstration.
Test room acoustics, remote and in-person encounters, interruptions, multiple speakers, accent variation, consent handling, pause and resume, and device failure.
Separate harmless wording edits from material omissions, unsupported facts, medicine or dose errors, negation errors, attribution mistakes, and unsafe plan changes.
Request current architecture, processing schedule, sub-processors, retention, security controls, incident process, accessibility evidence, support model, and change-notification terms.
Decision record
Keep the test cases, rubric, output corrections, evidence pack, unresolved risks, and approval conditions together. A later reviewer should be able to understand why the product was accepted, limited, or rejected.
Continue exploring
These pages add the operational, documentation, and trust context around this topic.
Next step
Use a representative workflow, a pre-agreed rubric, and current vendor evidence before deciding whether to adopt.